Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) EPS (Basic) (2018 - 2025)

Select Medical Holdings (SEM) has disclosed EPS (Basic) for 8 consecutive years, with $0.17 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 113.39% to $0.17 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.16, a 825.0% increase, with the full-year FY2025 number at $1.16, up 127.45% from a year prior.
  • EPS (Basic) was $0.17 for Q4 2025 at Select Medical Holdings, down from $0.23 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.22 in Q2 2021 to a low of -$1.27 in Q4 2024.
  • A 5-year average of $0.16 and a median of $0.22 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): crashed 405.41% in 2022, then skyrocketed 1050.0% in 2024.
  • Select Medical Holdings' EPS (Basic) stood at $0.37 in 2021, then plummeted by 405.41% to -$1.13 in 2022, then increased by 3.54% to -$1.09 in 2023, then dropped by 16.51% to -$1.27 in 2024, then skyrocketed by 113.39% to $0.17 in 2025.
  • Per Business Quant, the three most recent readings for SEM's EPS (Basic) are $0.17 (Q4 2025), $0.23 (Q3 2025), and $0.32 (Q2 2025).